CIPLA LTD.

Hepcdac

HEPCDAC contains Drug / Molecule “DACLATASVIR”. Hepcdac 60 mg Tablet is used in combination with other medications such as sofosbuvir, interferon and ribavirin for the treatment of hepatitis C infection.

Details
Specification

Indication

HEPCDAC is used with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 or genotype 3 infection.

Note

Precaution

Hepcdac is a prescription drug and should be used under proper medical guidance and advice.

Updated On Oct 19, 2019 by Admin

Strength

60 mg

Packing

1*28 Tablets (Plastic Container)

Storage

Store at a Temperature not exceeding 30 C

Was this page helpful?

☆ ☆ ☆ ☆ ☆

Not Upto Date Insufficient Helpful

Any suggestions or inputs for Shubhampharma.

Call us today

(+91) 8451008889

Hepcdac (60 mg): Check Drug Details and Specifications

Hepcdac

Indication

Note

Precaution

Strength

Packing

Storage

Was this page helpful?

Related Products

Velpanat

Sofosbuvir & velpatasvir-velpanat

Ledifos

Mydacla

Most Viewed Products

Abiraterone acetate-xbira

Bendamustine-bendit

Bicalutamide-cassotide

Bortezomib-bortenat

Erlonat

Everolimus-evertor

Exemestane-xtane

Geftinat

Glatiramer acetate-glatimer

Ledipasvir & sofosbuvir-hepcinat lp

Lenalidomide-lenalid

Pomalidomide-pomalid

Sofosbuvir & velpatasvir-velpanat

Sorafenib-sorafenat

Tenofovir-tenvir

Quick Query

Direct to your Phone